Engineering mRNA therapeutics for protein supplementation: Challenges and future horizons
BME Horizon · 2024
DOI: 10.70401/bmeh.2026.0025 ↗Kurz gefasst
Fachartikel in der Zeitschrift BME Horizon, 2024. Verfasst von Yiyang Tao und 5 weiteren Autor:innen. Die Arbeit nennt 111 Literaturangaben.
Abstract (Originalsprache)
Messenger RNA (mRNA) protein replacement therapy harnesses synthetic mRNA to direct endogenous protein synthesis, offering a versatile approach to restore or substitute proteins that are absent or dysfunctional in disease. Here, we review recent advances that have transformed this concept into a promising therapeutic platform, summarizing progress in mRNA design, delivery technologies, and preclinical and clinical applications across metabolic, oncological, and cardiovascular disorders. We also examine persistent challenges, including achieving precise tissue targeting, extending expression duration, and balancing immune tolerance with translation efficiency, that define the next frontier for clinical translation. By systematically analyzing these obstacles and evaluating emerging solutions, such as next-generation mRNA architectures, targeted biomaterial platforms, and programmable expression control, the review proposes new conceptual and technological directions for the next phase of mRNA therapeutic development. Collectively, these insights provide a structure for advancing mRNA protein replacement from proof-of-concept studies toward a broadly applicable platform for precision medicine.
Zitieren
APA
Tao, Y., Zhao, Y., Su, Q., Pan, J., Yin, J., & Xu, C. (2024). Engineering mRNA therapeutics for protein supplementation: Challenges and future horizons. BME Horizon. https://doi.org/10.70401/bmeh.2026.0025
Vancouver
Tao Y, Zhao Y, Su Q, Pan J, Yin J, Xu C. Engineering mRNA therapeutics for protein supplementation: Challenges and future horizons. BME Horizon. 2024. doi:10.70401/bmeh.2026.0025
BibTeX
@article{Tao2024,
author = {Tao, Yiyang and Zhao, Yue and Su, Qia and Pan, Jianxin and Yin, Jianguo and Xu, Congcong},
title = {Engineering mRNA therapeutics for protein supplementation: Challenges and future horizons},
journal = {BME Horizon},
year = {2024},
doi = {10.70401/bmeh.2026.0025}
}
EUVIMED